Why the study?
Does the Rhythmia mapping system enable minimal or zero-fluoroscopy transcatheter ablation of right-sided SVT without affecting safety and efficacy?
Does the Rhythmia mapping system enable minimal or zero-fluoroscopy transcatheter ablation of right-sided SVT without affecting safety and efficacy?
The Rhythmia mapping system allows for safe and effective right-sided SVT ablation with minimal or zero fluoroscopy.
May support minimal-fluoroscopy right-sided SVT ablation; leaves open confirmation in randomized trials.
The Rhythmia mapping system permits transcatheter ablation of right-sided SVT with minimal fluoroscopy exposure. Even more, in most cases, the system enables a ZF approach, without affecting safety and efficacy.
No takes yet. Share an insight, caveat, or question.
Cauti et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: